Trends in prescriptions for highly active antiretroviral therapy in four New York City HIV clinics

Article Abstract:

Most HIV patients are now taking highly active antiretroviral therapy (HAART), according to a survey of four New York City HIV clinics. In 1998, HAART prescriptions made up 89% of all AIDS drug prescriptions, up from 54% in 1997. Patients who were relatively healthy were just as likely to receive HAART as those who were most sick.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy

Article Abstract:

Immune system cells called monocytes may act as a reservoir of infectious HIV in patients receiving highly active antiretroviral therapy (HAART). This was the conclusion of a study of five such patients, all of whom had undetectable blood levels of the virus.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Development of in vitro resistence to macrophage-tropic- and T-cell-line-adapted HIV-1 strains among HIV-positive volunteers treated with highly active antiretroviral therapy

Article Abstract:

After six months of highly active antiretroviral therapy (HAART), five HIV patients who were susceptible to HIV became resistant. This was marked by a drop in viral levels and an increase in CD4+ T cell counts.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: